An approach to heart failure and diabetes mellitus

American Journal of Cardiology

Volumn 96, Issue 4 SUPPL., 2005, Pages 47-52

  Fonarow, Gregg C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPLERENONE; METOPROLOL SUCCINATE; PLACEBO; RAMIPRIL; SPIRONOLACTONE;

CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; DEATH; DIABETES MELLITUS; DYSLIPIDEMIA; EVIDENCE BASED MEDICINE; HEART FAILURE; HORMONE ACTION; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; INCIDENCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MICROANGIOPATHY; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR;

EID: 23744487440     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.06.005     Document Type: Conference Paper

References (33)

1. S.A. Hunt, D.W. Baker, M.H. Chin, M.P. Cinquegrani, A.M. Feldman, G.S. Francis, T.G. Ganiats, S. Goldstein, G. Gregoratos, M.L. Jessup American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure) ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult executive summary J Am Coll Cardiol 38 2001 2101 2113
2. W.B. Kannel, M. Hjortland, W.P. Castelli Role of diabetes in congestive heart failure the Framingham study Am J Cardiol 34 1974 29 34
3. K.K. Ho, J.L. Pinsky, W.B. Kannel, D. Levy The epidemiology of heart failure the Framingham study J Am Coll Cardiol 22 1993 6A 13A
4. J.A. Beckman, M.A. Creager, P. Libby Diabetes and atherosclerosis epidemiology, pathophysiology, and management JAMA 287 2002 2570 2581
5. G.M. Reaven, H. Lithell, L. Landsberg Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system N Engl J Med 334 1996 374 381
6. I.M. Stratton, A.I. Adler, H.A. Neil, D.R. Matthews, S.E. Manley, C.A. Cull, D. Hadden, R.C. Turner, R.R. Holman Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35) prospective observational study BMJ 321 2000 405 412
7. C. Iribarren, A.J. Karter, A.S. Go, A. Ferrara, J.Y. Liu, S. Sidney, J.V. Selby Glycemic control and heart failure among adult patients with diabetes Circulation 103 2001 2668 2673
8. A. Tenenbaum, M. Motro, E.Z. Fisman, J. Leor, D. Freimark, V. Boyko, L. Mandelzweig, Y. Adler, Y. Sherer, S. Behar Functional class in patients with heart failure is associated with the development of diabetes Am J Med 114 2003 271 275
9. American Heart Association Heart and Stroke Statistical Update, 2004 2004 American Heart Association Dallas, TX
10. D.M. Shindler, J.B. Kostis, S. Yusuf, M.A. Quinones, B. Pitt, D. Stewart, T. Pinkett, J.K. Ghali, A.C. Wilson Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) trials and registry Am J Cardiol 77 1996 1017 1020
11. G.A. Nichols, T.A. Hillier, J.R. Erbey, J.B. Brown Congestive heart failure in type 2 diabetes prevalence, incidence, and risk factors Diabetes Care 24 2001 1614 1619
12. D.L. Dries, N.K. Sweitzer, M.H. Drazner, L.W. Stevenson, B.J. Gersh Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction J Am Coll Cardiol 38 2001 421 480
13. A. Mosterd, B. Cost, A.W. Hoes, M.C. de Bruijne, J.W. Deckers, A. Hofman, D.E. Grobbee The prognosis of heart failure in the general population the Rotterdam study Eur Heart J 22 2001 1318 1327
14. J.B. Croft, W.H. Giles, R.A. Pollard, N.L. Keenan, M.L. Casper, R.F. Anda Heart failure survival among older adults in the United States a poor prognosis for an emerging epidemic in the Medicare population Arch Intern Med 159 1999 505 510
15. M. Packer The neurohormonal hypothesis a theory to explain the mechanism of disease progression in heart failure J Am Coll Cardiol 20 1992 248 254
16. R.J. Cody The sympathetic nervous system and the renin-angiotensin- aldosterone system in cardiovascular disease Am J Cardiol 80 1997 9J 14J
17. I. Gavras, H. Gavras Angiotensin II as a cardiovascular risk factor J Hum Hypertens 16 suppl 2 2002 S2 S6
18. P. Palatini Sympathetic overactivity in hypertension a risk factor for cardiovascular disease Curr Hypertens Rep 3 suppl 1 2001 S3 S9
19. G.D. Lopaschuk Metabolic abnormalities in the diabetic heart Heart Fail Rev 7 2002 149 159
20. M.J. Tansey, L.H. Opie Relation between plasma free fatty acids and arrhythmias within the first twelve hours of acute myocardial infarction Lancet 2 1983 419 422
21. P. Razeghi, M.E. Young, T.C. Cockrill, O.H. Frazier, H. Taegtmeyer Downregulation of myocardial myocyte enhancer factor 2C and myocyte enhancer factor 2C-regulated gene expression in diabetic patients with nonischemic heart failure Circulation 106 2002 407 411
22. P. Razeghi, M.E. Young, J.L. Alcorn, C.S. Moravec, O.H. Frazier, H. Taegtmeyer Metabolic gene expression in fetal and failing human heart Circulation 104 2001 2923 2931
23. S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, G. Dagenais Heart Outcomes Prevention Evaluation Study Investigators Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients [published corrections appear in N Engl J Med 2000;342:748 and 2000;342:1376] N Engl J Med 342 2000 145 153
24. Heart Outcomes Prevention Evaluation Study Investigators Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus results of the HOPE study and MICRO-HOPE substudy [published correction appears in Lancet 2000;356:860] Lancet 355 2000 253 259
25. R. Garg, S. Yusuf Collaborative Group on ACE Inhibitor Trials Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure JAMA 273 1995 1450 1456
26. P.G. Shekelle, M.W. Rich, S.C. Morton, C.S. Atkinson, W. Tu, M. Maglione, S. Rhodes, M. Barrett, G.C. Fonarow, B. Greenberg Efficacy of ACE inhibitors and beta blockers in the management of left ventricular systolic dysfunction according to race, sex, and diabetic status a meta-analysis of major clinical trials J Am Coll Cardiol 41 2003 1529 1538
27. B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, A. Perez, J. Palensky, J. Wittes Randomized Aldactone Evaluation Study Investigators The effect of spironolactone on morbidity and mortality in patients with severe heart failure N Engl J Med 341 1999 709 717
28. B. Pitt, W. Remme, F. Zannad, J. Neaton, F. Martinez, B. Roniker, R. Bittman, S. Hurley, J. Kleiman, M. Gatlin Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321
29. UK Prospective Diabetes Study Group Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes UKPDS 38 [published correction appears in BMJ 1999;318:29] BMJ 317 1998 703 713
30. The MERIT-HF Investigators Effect of metoprolol CR/XL in chronic heart failure Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 1999 2001 2007
31. M. Packer, M.R. Bristow, J.N. Cohn, W.S. Colucci, M.B. Fowler, E.M. Gilbert, N.H. Shusterman US Carvedilol Heart Failure Study Group The effect of carvedilol on morbidity and mortality in patients with chronic heart failure N Engl J Med 334 1996 1349 1355
32. CIBIS-II Investigators The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) a randomised trial Lancet 353 1999 9 13
33. M. Packer, A.J.S. Coats, M.B. Fowler, H.A. Katus, H. Krum, P. Mohacsi, J.L. Rouleau, M. Tendera, A. Castaigne, E.B. Roecker Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 2001 1651 1658